In the AF of the affected girl, T, d were also drastically elevated, PS, preg and 170Hpreg were just above normal limits (NL), while the other hormones were normal. Similarly T, A4 and OHP were drastically elevated in the peripheral blood a t birth. In contrast none of the estimations in the cord blood would have made the dgs with certainty, although OHP was above normal.
In Fetal HLA typing was performed in a 13 weeks pregnant woman for the prenatal diagnosis of 21 OH DAH. She was the mother of an '11 year old girl with late-onset 21 OH DAH (first clinical manifes tations appeared at the age of 9 years). HLA typing of the father, mother and child were respectively A3B7/A9B17, A2B5/A2BW38 and A3B7/A2B5. The fetal HWL typing was done on amniotic fluid cells and found to be A3B7/A2B5 ie identical to the haplotype of the affected daughter. The parents wished that the pregnancy be terminated if there was any chance for the fetus to be affected. Termination of the pregnancy was done at 17 weeks of gestation despite the fact that amniotic fluid st-eroid concentrations suggested an unaffected female fetus (ng/dl : 17 hydroxyproges"rone : 156, testosterone : 4.5, A 4 androstenedione : 78). The autopsy showed a normal female fetus. This painful experience gives support to the individualization of an acquired 21 OH DAH genetically different (and possibly clinically as well : only girls with lateonset virilisation have been reported so far) from the congenital form and indicates that prenatal diagnosis of the affection should not be based upon fetal HLA typing only. HLA typing was performed in a family with a child affected by salt-wasting CAH due to 21-OH deficiency. Father.mother, sister were clinically normal, with absence of signs of virilization or salt-wasting symptoms, normal stature and fertility. Based on the linkage of the gene for 21-OH deficiency to the HLA complex, the sister resulted heterozygous for the gene of CAH: a)A3,8~47,Cw6,DRw7 c)A2,87,DRw2 blAJ,BId.DRwi ~) A~, E I~. D R W~ *)died at 3 weeks,with vomiting and diarrhea Thrpe heterozygous members were therefore found in this family: father,mother,sister. Heterozygous carriers of the CAH-gene are expected to have normal baseline hormone 1evels.On the contrary father and sister were found to have abnormally elevated hormone levels, even if clinically normal.Both have the CAH gene-linked haplotype ("a"in father, "c"iv sister) and the "b" haplotype. It is speculated that the biochemical abnormalities in absence of clinical signs are the result of the combi~ation of a gene for a mild 21-OH defect (linked to the "b" haplotype) with the gene for the severe 21-OH defect (linked to "a" and "c" haplotype).
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The patient is the second child of healthy unrelated parents.his older brother is normal. At birth the genitalia were ambiguous; the phallus was adequate in size but there was chordee and peri= neal hypospadias. The labio-scrota1 folds were fused. Gonads were palpable in both groins. The karyotype (blood and skin) was nor= ma1 female XX. Biopsy of both gonads showed immature testes with no ovarian elements; the XX genotype was confirmed in gonadal ti? sue. Laparotomy showed normal male and absent female internal gp nitalia. Hypospadias repair was undertaken and the child was r e : red in the male sex. At 6 years he was noted to be virilising.He had shown rapid growth and weight gain and development of pubic and axillary hair. Plasma steroids by RIA and urinary steroidsby GLC/MS indicated partial 21-hydroxylase deficiency. There was normal suppression with exogenous steroids and a selenocholesterol scan showed bilateral adrenal hyperplasia.He is maintainedon hydro-cortisone and continues to make a good progress at the age of 9.This patient has an apparently unique combination C-f genetic endocrine defects unlikely to be due to chance.Tt is possibletkt translocation of part of a Y chromosome has influenced the ex= pression of the 21-hydroxylase locus on chromosome 6. Subjects affected by pituitary dwarfism and treated with Growth Hormone (GH) preparations extracted according to the Raben proce= dure have a high incidence of anti-GH antibodies. These antibodies were detected in 7 out of 22 patients treated with the GRORM (Se= rono) clinical preparation. Two of them showed a significantly im= paired growth rate (19 and 28% less than the mean value in the other 20 patients). Their sera bound labelled GH with a high affix nity (Kar 0.66 and 1 .I6 x IO-~M). The binding capacity was 0.32 and 0.75 mgGH/l, respectively. We fractionated the GRORM prepara= tion by gel filtration (Sephadex G-100) and tested the two sera with different protein peaks. The fraction having a m.w.of 80,000, a Kav of 0.20 and an immunoreactivity equal to 84% of the GH mono= mer was bound more and with a higher association rate. This frac= tion is 12-24% of the GRORM preparation and it probably consists of GH aggregates. The present data suggests a major role of the GH aggregates in eliciting anti-GH antibodies production in these patients.
